Instadose Canada is reviewing its relationship with the Democratic Republic of Congo after officials seized 18 tons of medicinal cannabis bound for North Macedonia in June 2021. Cannabiz Africa understands that the consignment is being kept under guard by the country’s National Intelligence Agency while Instadose tries to “clear up outstanding paperwork”.

Ibogaine’s healing properties are as yet to be thoroughly researched and Gabon’s sacred plant is classified as a Schedule 1 substance in the US because of its psychoactive effects. However, it increasingly being used by opioid detox clinics in Mexico, New Zealand and the Netherlands as its popularity grows rapidly, despite the dangers associated with it.

The world is waking up to the power of African medicine. Gabon’s sacred plant, Ibogaine, is increasingly in demand because of its powerful healing properties.

Nasdaq-listed Akanda may have exited Lesotho, but the Battle for Bophelo continues between lawyers in London as the company takes on its former chairperson Louisa Mojela over the unauthorized liquidation of its local subsidiary. Akanda says Bophelo's management team received excessive compensation for poor performance and wants to recover 900 000 British pounds.

The Indian Ocean Island of Mauritius has amended its Dangerous Drugs Act 2000 to decriminalize cannabis for certain medical conditions. It has issued no date for the implementation of the proposed guidelines and says cannabis cultivation is not part of the plan.

Akanda has dropped almost US$11 million in last six months and CEO Tej Virk has been placed on “paid leave of absence for administrative and personal reasons” as the Nasdaq-listed group struggles to find its way between European opportunity and destruction of shareholder value.

Acting on a tip-off, Zimbabwe police raided the Pinnacle Baptist Church Stand, in Westlea, Harare where they found 700 cannabis plants and arrested one person.

Malawi seeks to develop the hemp industry to make up for declining earnings from the tobacco sector. However, authorities have been criticized for the high cost of license fees. At US$!0 000 this is way out of reach for most small-scale tobacco farmers.

The Global Cannabis Report 2022 says that Zambia moved early to legalize the export of medical cannabis but has made little progress because of the constant economic turmoil in the country. It says it will be some time before there’s any meaningful development on the cannabis front in Zambia.

The Global Cannabis Report 2022 says Rwanda is likely to follow South Africa in opening up a domestic market for cannabinoid products. Although non-medical use is prohibited, Rwanda may pay a pivotal role in liberalising attitudes towards cannabis in East and Central Africa.

The Global Cannabis Report says that over the next few years, Uganda is a market worth watching as it has clearly demonstrated an ability to meet international import standards. However, the industry is limited in that only one export license has been granted – to the local subsidiary of Israeli multinational Together Pharma.

The Global Cannabis Report 2022 says Zimbabwe has renewed its focus on developing its hemp and cannabis industries as economic drivers to try and pull the country out of its financial mire and provide an alternative revenue source to tobacco exports.